Pantumor MRD-undersøgelse
Molecular Residual Disease in Solid Tumors: En prospektiv undersøgelse til indsamling af kliniske data og bioprøver til støtte for opdagelse og udvikling af cancerbiomarkører
The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back.
Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Anosheh Afghahi, MD
- Telefonnummer: 888-662-6367
- E-mail: anosheh.afghahi@paradigmhealth.ai
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35205
- Rekruttering
- Alabama Oncology
-
Kontakt:
- Kailee Hawkins
- Telefonnummer: 919-368-3285
- E-mail: kailee.hawkins@alabamaoncology.com
-
Ledende efterforsker:
- Carter Capra
-
-
Arizona
-
Bullhead City, Arizona, Forenede Stater, 86442
- Rekruttering
- Mohtaseb Cancer Center and Blood Disorders
-
Ledende efterforsker:
- Hamdy Mohtaseb
-
Kontakt:
- Stephanye Vargas
- Telefonnummer: 928-219-4560
- E-mail: stephanye@azcancerandblood.com
-
Casa Grande, Arizona, Forenede Stater, 85122
- Rekruttering
- Cancer & Blood Specialists of Arizona
-
Kontakt:
- Robin Wilson
- Telefonnummer: 520-836-9800
- E-mail: robin.wilson@aoncology.com
-
Ledende efterforsker:
- Carlos Arce-Lara
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater, 72205
- Rekruttering
- CARTI
-
Kontakt:
- Carla Randall
- Telefonnummer: 501-906-3012
- E-mail: Crandall@carti.com
-
Ledende efterforsker:
- Andrew Briggler
-
Springdale, Arkansas, Forenede Stater, 72762
- Rekruttering
- Highlands Oncology Group (HOG)
-
Ledende efterforsker:
- Joseph Beck
-
Kontakt:
- Tina Patrick
- Telefonnummer: 479-872-8130
- E-mail: tpatrick@hogonc.com
-
-
California
-
Glendale, California, Forenede Stater, 91204
- Rekruttering
- Los Angeles Cancer Network (LACN)
-
Kontakt:
- Robert Milford
- Telefonnummer: (323) 794-1132 Ext: 3734
- E-mail: robert.milford@lahomg.com
-
Ledende efterforsker:
- Peyman Salimi-Tari
-
Oxnard, California, Forenede Stater, 93030
- Rekruttering
- Ventura County Hematology Oncology Specialists
-
Kontakt:
- Cheryl Senour
- Telefonnummer: 805-485-8709 x 121
- E-mail: csenour@venturaoncology.com
-
Ledende efterforsker:
- Lynn Kong
-
San Diego, California, Forenede Stater, 92123
- Rekruttering
- Medical Oncology Associates of San Diego
-
Kontakt:
- Alexis Bustamante
- E-mail: abustamante@oncologysandiego.com
-
San Diego, California, Forenede Stater, 92123
- Rekruttering
- Medical Oncology Associates of San Diego (MOASD)
-
Kontakt:
- Amanda Somo
- Telefonnummer: (858) 637-7888 ext 224
- E-mail: asomo@oncologysandiego.com
-
Ledende efterforsker:
- James Coggan
-
Stockton, California, Forenede Stater, 95204
- Rekruttering
- Stockton Hematology Oncology Med Group
-
Kontakt:
- Lenzi Cook
- Telefonnummer: 209-938-3106
- E-mail: lcook@shomg.net
-
Ledende efterforsker:
- Sunny Phillip
-
-
Colorado
-
Englewood, Colorado, Forenede Stater, 80113
- Rekruttering
- The Melanoma and Skin Cancer Institute
-
Kontakt:
- Sydney Harris
- Telefonnummer: 720-316-8091 extn 101
- E-mail: sydney.harris@theskincancerinstitute.com
-
Ledende efterforsker:
- Ryan Weight
-
-
Florida
-
Coral Springs, Florida, Forenede Stater, 33065
- Rekruttering
- Oncology & Hematology Associates of West Broward
-
Ledende efterforsker:
- Sumit Sawhney
-
Kontakt:
- Margie Murillo
- Telefonnummer: 954 726 0035 x1230
- E-mail: margie.murillo@ohawb.com
-
Orange City, Florida, Forenede Stater, 32763
- Rekruttering
- Mid Florida Cancer Centers
-
Ledende efterforsker:
- Santosh Nair
-
Kontakt:
- Kiran Penta
- Telefonnummer: 386-538-3169
- E-mail: Kiran@aocorp.com
-
St. Petersburg, Florida, Forenede Stater, 33709
- Rekruttering
- Comprehensive Hematology Oncology (CHO)
-
Ledende efterforsker:
- Neeharika Makani
-
Kontakt:
- Raj Shah
- Telefonnummer: 727-344-6569 Ext 1036
- E-mail: rshah@comphemonc.com
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30318
- Rekruttering
- Piedmont Cancer Institute
-
Kontakt:
- Katie Adams
- Telefonnummer: 678-298-3238
- E-mail: kadams@piedmontcancerinstitute.com
-
Ledende efterforsker:
- Vasileios Assikis
-
-
Illinois
-
O'Fallon, Illinois, Forenede Stater, 62269
- Rekruttering
- Cancer Care Specialists of Illinois (CCSI)
-
Ledende efterforsker:
- James Wade
-
Kontakt:
- Kaitlynn Zeisset
- Telefonnummer: 618-589-9721
- E-mail: kzeisset@ccsci.net
-
Urbana, Illinois, Forenede Stater, 61801
- Rekruttering
- Carle Health
-
Kontakt:
- Christine Canfield
- Telefonnummer: (217) 326-0095
- E-mail: christine.canfield@carle.com
-
Ledende efterforsker:
- Christine Canfield
-
-
Kansas
-
Topeka, Kansas, Forenede Stater, 66606
- Rekruttering
- Cotton O'Neil Cancer Center [Stormont Vail]
-
Kontakt:
- Scott Harrison
- Telefonnummer: 785-270-4962
- E-mail: saharris@stormontvail.org
-
Ledende efterforsker:
- Mehmmod Hashmi
-
Wichita, Kansas, Forenede Stater, 67214
- Rekruttering
- Cancer Center of Kansas
-
Ledende efterforsker:
- Shaker Dakhil
-
Kontakt:
- Kristen Mazowiecki
- Telefonnummer: (316) 613-4326
- E-mail: kristen.mazowiecki@cancercenterofkansas.com
-
-
Kentucky
-
Corbin, Kentucky, Forenede Stater, 40701
- Rekruttering
- Baptist Health Corbin
-
Kontakt:
- Janie Platt
- Telefonnummer: 859.260.6406
- E-mail: Janie.platt@bhsi.com
-
Ledende efterforsker:
- Abigail Byrnes
-
Elizabethtown, Kentucky, Forenede Stater, 42701
- Rekruttering
- Baptist Health Hardin
-
Kontakt:
- Kristen Lerch
- Telefonnummer: 270-979-2686
- E-mail: Kristen.Lerch@bhsi.com
-
Ledende efterforsker:
- Christopher Burkeen
-
Lexington, Kentucky, Forenede Stater, 40503
- Rekruttering
- Baptist Health Lexington
-
Ledende efterforsker:
- Arvinda Padmanabhan
-
Kontakt:
- Tory Tincher
- Telefonnummer: 859.260.6464
- E-mail: Tory.Tincher@bhsi.com
-
Louisville, Kentucky, Forenede Stater, 40207
- Rekruttering
- Baptist Health Louisville
-
Ledende efterforsker:
- Wangjian Zhong
-
Kontakt:
- Kelly Strange
- Telefonnummer: 502.928.6103
- E-mail: Kelly.Strange@bhsi.com
-
-
Louisiana
-
Covington, Louisiana, Forenede Stater, 70433
- Rekruttering
- Pontchartrain Cancer Center
-
Ledende efterforsker:
- David Oubre
-
Kontakt:
- Ella Hunter
- Telefonnummer: 985-419 0025
- E-mail: ella@pcclouisiana.com
-
Shreveport, Louisiana, Forenede Stater, 71105
- Rekruttering
- Christus Health Highlands
-
Kontakt:
- Nancy Hassan
- Telefonnummer: 318.681.4763
- E-mail: nancy.senniah@christushealth.org
-
Ledende efterforsker:
- Neelima Chintapalli
-
-
Michigan
-
Grand Rapids, Michigan, Forenede Stater, 49546
- Rekruttering
- The Cancer & Hematology Centers (CHC)
-
Kontakt:
- Maci Deboer
- Telefonnummer: (616) 954-5550 Ext. 1925
- E-mail: mdeboer@hcwm.com
-
Ledende efterforsker:
- Joy Bartholomew
-
-
Minnesota
-
Rochester, Minnesota, Forenede Stater, 55905
- Rekruttering
- Mayo Clinic
-
Kontakt:
- Lauren Helgeson
- Telefonnummer: 507-266-3718
- E-mail: helgeson.lauren@mayo.edu
-
Ledende efterforsker:
- Lisa Boardman
-
-
Missouri
-
Springfield, Missouri, Forenede Stater, 65807
- Rekruttering
- Cox Health
-
Kontakt:
- Tala Abu Zahra
- Telefonnummer: 417-269-7114
- E-mail: Tala.AbuZahra@coxhealth.com
-
Ledende efterforsker:
- Rajesh Banderudrappagari
-
-
Nebraska
-
Lincoln, Nebraska, Forenede Stater, 68516
- Rekruttering
- Cancer Partners of Nebraska
-
Kontakt:
- Candice Toombs
- Telefonnummer: 402-327-7363
- E-mail: candicet@cancerpartners.com
-
Ledende efterforsker:
- Stacey Knox
-
-
New Mexico
-
Farmington, New Mexico, Forenede Stater, 87401
- Rekruttering
- San Juan Oncology Associates
-
Ledende efterforsker:
- Sardar Imam
-
Kontakt:
- Jessica Barnes
- Telefonnummer: (505)564-6850 ext 875
- E-mail: jessica@sjonc.com
-
-
New York
-
Binghamton, New York, Forenede Stater, 13905
- Rekruttering
- Guthrie Lourdes Memorial Hospital (GLMH)
-
Ledende efterforsker:
- Beka Aroshidze
-
Kontakt:
- Colleen English
- Telefonnummer: (607)798-5734
- E-mail: colleenh.english@guthrie.org
-
Shirley, New York, Forenede Stater, 11967
- Rekruttering
- New York Cancer & Blood Specialists
-
Ledende efterforsker:
- Richard Zuniga
-
Kontakt:
- Stella Smaragdas
- Telefonnummer: 631-675-5075
- E-mail: ssmaragdas@nycancer.com
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28207
- Rekruttering
- Carolina Oncology Specialists
-
Ledende efterforsker:
- Justin Favaro
-
Kontakt:
- Tine Ekhaiyeme
- Telefonnummer: 704-342-1900 Ext 1126
- E-mail: aekhaiyeme@carolinaonco.com
-
Goldsboro, North Carolina, Forenede Stater, 27534
- Rekruttering
- Southeastern Medical Oncology Center (SMOC)
-
Kontakt:
- Mackenzie Lupton
- Telefonnummer: 919-429-4318
- E-mail: mlupton@cancersmoc.com
-
Ledende efterforsker:
- Samer Kasbari
-
Wilson, North Carolina, Forenede Stater, 27893
- Rekruttering
- Regional Medical Oncology Center
-
Ledende efterforsker:
- Keith Lerro
-
Kontakt:
- Meredith Best
- Telefonnummer: (252) 991-5261
- E-mail: meredith.best@regionaloncology.com
-
-
Ohio
-
Canton, Ohio, Forenede Stater, 44718
- Rekruttering
- Gabrail Cancer Center
-
Ledende efterforsker:
- Nashat Gabrail
-
Kontakt:
- Carrie Smith
- Telefonnummer: 330-417-8231
- E-mail: csmith@gabrailcancercenter.com
-
Maumee, Ohio, Forenede Stater, 43437
- Rekruttering
- Taylor Cancer Research Center
-
Kontakt:
- Jennifer Martinez
- Telefonnummer: ext 4134 419-479-5605
- E-mail: jmartinez@toledoclinic.com
-
-
Oklahoma
-
Tulsa, Oklahoma, Forenede Stater, 74129
- Rekruttering
- Oklahoma Cancer Specialists and Research Institute (OCSRI)
-
Kontakt:
- Stephanie Sandoval
- Telefonnummer: 918-568-6759
- E-mail: stephanie.sandoval@ocsri.org
-
Ledende efterforsker:
- Scott Cole
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97201
- Rekruttering
- Oregon Health & Science University (OHSU)
-
Ledende efterforsker:
- Nima Nabavizadeh
-
Kontakt:
- Francis DeAsis
- Telefonnummer: (503) 418-8155
- E-mail: deasis@ohsu.edu
-
-
Pennsylvania
-
Lancaster, Pennsylvania, Forenede Stater, 17601
- Rekruttering
- Lancaster General Hospital (UPenn)
-
Kontakt:
- Susan Tollett
- Telefonnummer: 717-544-0511
- E-mail: susan.tollett@pennmedicine.upenn.edu
-
Ledende efterforsker:
- Efrat Dotan
-
Sayre, Pennsylvania, Forenede Stater, 18840
- Rekruttering
- Guthrie Foundation
-
Kontakt:
- Jackie Cole
- Telefonnummer: (570)887-6071
- E-mail: jacqueline.cole@guthrie.org
-
Ledende efterforsker:
- Rebekah Macfie
-
York, Pennsylvania, Forenede Stater, 17403
- Rekruttering
- Cancer Care Associates of York (CCAY)
-
Ledende efterforsker:
- Chanh Huynh
-
Kontakt:
- Clarissa Vega
- Telefonnummer: 717-741-9229 EXT: 147
- E-mail: cvega@cancercareyork.com
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- Onocology Consultants P.A. (Oncology Consultants [OC Houston])
-
Ledende efterforsker:
- Julio Peguero
-
Kontakt:
- Marisol Dominguez
- Telefonnummer: (832) 333-1480
- E-mail: marisol.dominguez@aoncology.com
-
Kingwood, Texas, Forenede Stater, 77339
- Rekruttering
- Community Clinical Trials
-
Ledende efterforsker:
- Saleha Sajid
-
Kontakt:
- Kemi Stewart
- Telefonnummer: 325-298-7478
- E-mail: kemi@communityclinicaltrials.com
-
Texarkana, Texas, Forenede Stater, 75503
- Rekruttering
- Christus St. Michael's
-
Ledende efterforsker:
- Sunil Patel
-
Kontakt:
- Kimberly Everett
- Telefonnummer: 903-614-6885
- E-mail: kimberly.everett@christushealth.org
-
-
Virginia
-
Richmond, Virginia, Forenede Stater, 23229
- Rekruttering
- Virginia Cancer Institute
-
Kontakt:
- Christine Mathews
- Telefonnummer: 1-804-287-3000 ext 1260
- E-mail: cmathews@vacancer.com
-
Ledende efterforsker:
- Susan Moore
-
-
Washington
-
Tacoma, Washington, Forenede Stater, 98405
- Rekruttering
- Northwest Medical Specialties (NWMS)
-
Kontakt:
- Erma Sanders
- Telefonnummer: 253-428-8700
- E-mail: esanders@nwmsonline.com
-
Ledende efterforsker:
- Manas Agastya
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Study participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors
Beskrivelse
Eligibility Criteria:
-
Age 18 years or older.
-
Confirmed histological or cytological diagnosis of a malignant solid tumor that is either specified in one of the pre-defined tumor cohorts or meets the enrollment criteria for the Mix of Solid Tumors (MOST) cohort (Table 1).
-
Eligible for curative intent therapy, with surgical resection of cancer planned.
a. If surgical resection has occurred, enrollment should occur within 3 months of surgical resection and before initiation of adjuvant therapy.
-
Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2.
-
No systemic therapy for current cancer diagnosis administered before enrollment.
-
Willing and able to comply with required study procedures, including blood sample collection and primary tumor tissue submission from diagnostic biopsy or surgical excision.
-
Has completed all therapy (including endocrine therapy) 3 or more years ago for any previous invasive solid organ malignancy (with exception of nonmelanoma skin cancers) or hematologic malignancy. Individuals with a prior history of noninvasive (in situ) carcinomas may participate if they have received definitive treatment (no washout period required).
-
No concurrent diagnosis of another invasive cancer, except for nonmelanoma skin cancers.
-
No prior allogeneic hematopoietic stem cell transplant.
-
Able and willing to provide informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information.
Cohort Specific Criteria
-
Muscle-invasive urothelial carcinoma of the bladder and Melanoma Cohorts: Stage II or operable III cancer:
-
Esophageal, Gastric/GEJ, and NSCLC Cohorts: Stage I, II, or operable III cancer.
-
Pancreatic Cohort: Stage I, II or operable III cancer, exocrine only disease.
-
MOST cohort: Stage II or operable stage III solid tumor diagnosis that meets eligibility criteria and is not included in the other cohorts.
The following tumor types are excluded:
-
Central nervous system (CNS) malignancies
-
Colorectal cancer
-
Breast cancer
-
Squamous cell skin cancer
-
Basal cell carcinoma
-
Gastrointestinal stromal tumors (GIST)
-
Thyroid cancer
-
Uveal melanoma
-
Low or intermediate grade neuroendocrine tumors
■ Eligible tumor types: High-grade neuroendocrine tumors, including neuroendocrine carcinomas, Merkel cell carcinomas, and small cell lung cancer are permissible
-
Hematologic cancers including multiple myeloma or other plasma cell dyscrasias, Hodgkin's lymphoma, non-Hodgkin's lymphoma, acute or chronic leukemias including chronic lymphocytic leukemia / small lymphocytic leukemia
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)
Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC) |
routine standard of care Routine standard of care |
|
Esophageal
Esophageal cancer |
routine standard of care Routine standard of care |
|
Gastric and Gastroesophageal Junction (GEJ)
Gastric and Gastroesophageal Junction (GEJ) |
routine standard of care Routine standard of care |
|
Melanoma
Melanoma |
routine standard of care Routine standard of care |
|
Non-small cell lung (NSCLC)
Non-small cell lung (NSCLC) |
routine standard of care Routine standard of care |
|
Pancreatic (exocrine only)
Pancreatic (exocrine only) |
routine standard of care Routine standard of care |
|
Mix of Solid Tumors (MOST)
Mix of Solid Tumors (MOST) |
routine standard of care Routine standard of care |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Blood and tissue biospecimen registry
Tidsramme: Observation from enrollment to 5.5 years after enrollment
|
To establish a blood and tissue biospecimen resource in participants with operable solid tumors, with clinical, lab, radiographic, and pathology annotation for the discovery, development, and validation of MRD assays. |
Observation from enrollment to 5.5 years after enrollment
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neoplasmer efter sted
- Neoplasmer
- Luftvejssygdomme
- Neoplasmer efter histologisk type
- Gastrointestinale neoplasmer
- Neoplasmer i fordøjelsessystemet
- Sygdomme i fordøjelsessystemet
- Gastrointestinale sygdomme
- Lungesygdomme
- Neoplasmer i hoved og hals
- Neoplasmer, kirtel og epitel
- Neoplasmer i luftvejene
- Thoracale neoplasmer
- Esophageale sygdomme
- Lungeneoplasmer
- Hudsygdomme
- Karcinom
- Neuroektodermale tumorer
- Neoplasmer, kimceller og embryonale
- Neoplasmer, nervevæv
- Karcinom, bronkogent
- Bronkiale neoplasmer
- Neuroendokrine tumorer
- Nevi og melanomer
- Neoplasmer i huden
- Hud- og bindevævssygdomme
- Esophageale neoplasmer
- Karcinom, ikke-småcellet lunge
- Adenocarcinom
- Melanom
- Undersøgelsesteknikker
- Håndtering af eksemplar
- Kliniske laboratorieteknikker
- Diagnostiske teknikker og procedurer
- Diagnose
- Punkteringer
- Kirurgiske procedurer, operative
- Blodprøveopsamling
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- PHPE-07-002
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .